Filing Details
- Accession Number:
- 0001213900-23-029901
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-14 16:19:42
- Reporting Period:
- 2023-04-14
- Accepted Time:
- 2023-04-14 16:19:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1788028 | Jasper Therapeutics Inc. | JSPR | Biological Products, (No Disgnostic Substances) (2836) | 842984849 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1871871 | Louise Anna French | C/O Jasper Therapeutics, Inc. 2200 Bridge Pkwy, Suite #102 Redwood City CA 94065 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Voting Common Stock | Disposition | 2023-04-14 | 7,000 | $1.48 | 23,750 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold by the Reporting Person solely in order to satisfy certain tax obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units.
Billionaire Hedge Funds
